Co-delivery of an antisense oligonucleotide and 5-fluorouracil using sustained release poly (lactide-co-glycolide) microsphere formulations for potential combination therapy in cancer

International Journal of Pharmaceutics

Volumn 234, Issue 1-2, 2002, Pages 129-138

  Hussain, Majad ^a   Beale, Gary ^a   Hughes, Marcus ^a   Akhtar, Saghir ^a,b  

^a ASTON UNIVERSITY   (United Kingdom)

^b KUWAIT UNIVERSITY   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUOROURACIL; MICROSPHERE; OLIGODEOXYNUCLEOTIDE; POLYGLACTIN;

ARTICLE; CANCER; COMBINATION CHEMOTHERAPY; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG FORMULATION; DRUG TARGETING; ELECTROPHORETIC MOBILITY; EMULSION; IN VITRO STUDY; MODEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUSTAINED RELEASE PREPARATION;

ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DRUG COMBINATIONS; DRUG INTERACTIONS; ELECTROPHORESIS; FLUOROURACIL; LACTIC ACID; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; OLIGONUCLEOTIDES, ANTISENSE; PARTICLE SIZE; PHOSPHORUS RADIOISOTOPES; POLYGLYCOLIC ACID; POLYMERS;

EID: 0037006590     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(01)00950-4     Document Type: Article

References (21)

1. The delivery of antisense therapeutics
2. Antisense oligodeoxynucleotide delivery to cultured macrophages is improved by incorporation into sustained-release biodegradable polymer microspheres
3. In vivo studies with antisense oligonucleotides
4. An update on the biochemistry of 5-fluorouarcil
5. The development of new brain tumour therapy utilising the local and sustained delivery of chemotherapeutic agents from biodegradable polymers: Editorial
6. Effect of cisplatin and c-myb antisense phosphorothioate oligodeoxynucleotides combination on a human colon carcinoma cell line in vitro and in vivo
7. Polyalkylcyanoacrylate nanoparticles as polymeric carriers for antisense oligonucleotides
8. In vitro and in vivo evaluation of PLAGA (50/50) microspheres containing 5-fluorouracil prepared by a solvent evaporation method
9. A non-antisense sequence-selective effect of a phosphorothioate oligonucleotide targeted to EGFR in A431 cells
10. Biodegradable polyalkylcyanoacrylate nanoparticles for the delivery of antisense oligonucleotides
11. Antisense down-regulation of thymidylate synthase to suppress growth and enhance cytotoxicity of 5-Fudr, 5-FU and tomudex in HeLa cells
12. Antitumour activity of a PKC-α antisense oligonucleotides in combination with standard chemotherapeutic agents against various human tumours transplanted into nude mice
13. The cellular delivery of antisense oligonucleotides and ribozymes
14. Pharmacological effects of 5-fluorouracil microspheres on peritoneal carcinomatosis in animals
15. Site-specific administration of antisense oligonucleotides using biodegradable microspheres provides sustained delivery and improved subcellular biodistribution in the neostriatum of the rat brain
16. Biodegradable poly(L-lactic acid) matrices for the sustained delivery of antisense oligonucleotides
17. Development of a sustained release biodegradable polymer delivery system for site-specific delivery of oligonucelotides: Characterisation of P(LA-GA) copolymer microspheres in vitro
18. Local and sustained delivery of 5-fluorouracil from biodegradable microspheres for the radiosensitization of glioblastoma: A pilot study
19. Metabolism and mechanism of action of 5-fluorouracil
20. Co-operative antitumour effect of mixed backbone oligonucleotides targeting protein kinase A in combination with cytotoxic drugs or biologic agents
21. Combined effect of alpha-fetoprotein antisense oligodeoxy-nucleotides and 5-fluorouracil on human hepatoma cell growth